Cargando…
Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis
BACKGROUND: The treatment success rate of conventional anti-tuberculosis (TB) regimens for extensively drug-resistant TB (XDR-TB) is low, resulting in high morbidity and healthcare cost especially in the high TB burden countries. Recent clinical findings reported improved treatment outcomes of XDR-T...
Autores principales: | Fekadu, Ginenus, Yao, Jiaqi, You, Joyce H. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355220/ https://www.ncbi.nlm.nih.gov/pubmed/35930574 http://dx.doi.org/10.1371/journal.pone.0272770 |
Ejemplares similares
-
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
por: Gomez, Gabriela Beatriz, et al.
Publicado: (2021) -
Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
por: Fekadu, Ginenus, et al.
Publicado: (2022) -
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017) -
Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis
por: Gaida, Razia, et al.
Publicado: (2020) -
Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country
por: Fekadu, Ginenus, et al.
Publicado: (2021)